تداخلات سيفيبيم

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (نشرة إرتابينيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (نشرة إيميبينيم وسيلاستاتين، التحذيرات والاحتياطات)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (نشرة سيفيبيم، موانع الاستعمال)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (نشرة أزتريونام، التحذيرات والاحتياطات)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Aminoglycosides: Increased potential of nephrotoxicity and ototoxicity. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (نشرة بروبينيسيد، التداخلات الدوائية)

DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (نشرة بروبينيسيد وكولشيسين، التداخلات الدوائية)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (نشرة بروتامين، الاحتياطات)

Aminoglycosides: Increased potential of nephrotoxicity and ototoxicity. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Aminoglycosides: Increased potential of nephrotoxicity and ototoxicity. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Aminoglycosides: Increased potential of nephrotoxicity and ototoxicity. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Prothrombin time should be monitored in patients at risk, and exogenous vitamin K administered as indicated. (نشرة سيفيبيم، التحذيرات والاحتياطات)

Prothrombin time should be monitored in patients at risk, and exogenous vitamin K administered as indicated. (نشرة سيفيبيم، التحذيرات والاحتياطات)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (نشرة ميكوفينولات، التداخلات الدوائية)

Aminoglycosides: Increased potential of nephrotoxicity and ototoxicity. (نشرة سيفيبيم، التداخلات الدوائية)

Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (نشرة سيفيبيم، التداخلات الدوائية)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (نشرة ميروبينيم، التحذيرات والاحتياطات)